Items where authors include "Nash, D."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Hann, D. orcid.org/0000-0002-6217-4634, Latreille, P. orcid.org/0000-0001-7685-6532, Nash, D. orcid.org/0000-0002-1244-2231 et al. (1 more author) (2023) Custodians of contemporary pluralism? Acas' evolving role in addressing conflict during a time of economic and regulatory flux. Industrial Relations Journal, 54 (4-5). pp. 321-340. ISSN 0019-8692

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736